Acadia Pharmaceuticals (DR6.F) Q3 2024 Earnings

6AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.42
-0.19
0.04
0.27

Details

Expected EPS
0.16261424419999998
Actual EPS
0.183052
Surprise EPS
0.02
Surprise Percent
+12.57%

Description

Acadia Pharmaceuticals (DR6.F) has reported earnings of 0.183052 per share for Q3 2024.

0 Comments

Share your thoughts